Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib

Primary central nervous system lymphoma (PCNSL) is a rare subtype of extranodal non-Hodgkin lymphoma, and the most frequent histological type is diffuse large B‐cell lymphoma (DLBCL). Bruton’s tyrosine kinase inhibitor (BTKi) has shown clinical activity in DLBCL. We herein report a 53-year-old man w...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Qiansong, Wang, Jing, Lv, Chenglan, Xu, Jingyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163630/
https://www.ncbi.nlm.nih.gov/pubmed/34079282
http://dx.doi.org/10.2147/OTT.S309408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163630/
https://www.ncbi.nlm.nih.gov/pubmed/34079282
http://dx.doi.org/10.2147/OTT.S309408

Ejemplares similares